Amylyx

Like many patients suffering from amyotrophic lateral sclerosis, or ALS—also known as Lou Gehrig’s disease—Layne Oliff didn’t have any time to waste.Even before the drug Relyvrio was approved late last month by the Food and Drug Administration, he has had his own do-it-yourself method: he gets sodium phenylbutyrate in liquid form from a New Jersey pharmacy and taurursodiol online from Amazon. That costs him over $7,000 a year, but he says it has been well worth it because he feels the combination has helped stabilize a…

Check out the companies making headlines before the bell:Nike (NKE) – Nike slumped 10% in the premarket after it reported a 44% increase in inventories for its latest quarter, and said it would offer more discounts heading into the holiday season. The athletic footwear and apparel maker reported better-than-expected profit and revenue for its latest quarter.Micron Technology (MU) – Micron gained 1.5% in the premarket after it beat estimates with its latest quarterly earnings, even as sales fell below forecasts. The…

U.S. drug regulators approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis, or ALS, giving patients a new option for slowing progression of the fatal disease.The drug is the first that the Food and Drug Administration has approved for ALS, also known as Lou Gehrig’s disease, in five years and promises to extend the lives of patients by several months. “It’s a fantastic step forward in our fight against ALS,” said Sabrina Paganoni, the study’s lead researcher and…